Organovo Holdings Inc (ONVO) Quote

here is a better place to talk MMA https://investorshub.advfn.com/Mixed-Martial-Arts-MMA-UFC-Bellator-K-1-Glory-et-22925

ILIA IS A BAD ASS WITH BRILLIANT BOXING AND GROUND SKILLS...NOBODY IN HIS DIVISION WILL BEAT HIM FOR MANY MOONS

Flush!

He better stay away fro Ilia

that was wild, highlight reel for the record books

S-1 Offering
April 2024 S-1 Offering (size undisclosed)
EDGAR
In Progress

Anticipated Deal Size
$10,000,000
Status
In Progress
https://dilutiontracker.com/app/search/ONVO?a=dbb88c

1.59

Did you watch max get lucky over the weekend with his pathetic right. Wait until Ilia gets a hold of that little guy. He won’t last 2 minutes.

woaaah

TrendTrade2016

Member Level
Re: None

Monday, April 15, 2024 8:47:13 AM

Post#
10478
of 10478
Change your lifestyle and stop drinking so much alcohol and then maybe you won’t have fatty liver. Go on a fast ya fat slobs to give your liver a rest. Stop eating junk food filled with fructose. Smh

Change your lifestyle and stop drinking so much alcohol and then maybe you won’t have fatty liver. Go on a fast ya fat slobs to give your liver a rest. Stop eating junk food filled with fructose. Smh

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo

Still hodling these ONVO hoping SpaceX buys them out and then it's "To da moon!"

ONVO under $2

ONVO.................................https://stockcharts.com/h-sc/ui?s=ONVO&p=W&b=5&g=0&id=p86431144783

ONVO new 52 week low

From new 10Q. They dropped their burn rate a little more. Looking like 6 months of cash on hand starting Oct 1. They will need money before their new target data.

Date Cash Burn Rate
Friday, March 31, 2023 $15,301
Friday, June 30, 2023 $10,754 $4,547
Saturday, September 30, 2023 $7,617 $3,137

Not looking good with volume fading

I mean july-september

That was for april-june. Published in August. Should see another 10q any day now for july-august. Maybe only another 3 months left from now

6 months until cash runs out at current rate,or become profitable,or raise more cash via loan or create and sell shares

Looks like about 5m a quarter...

Cash and cash equivalents
June 30, 2023 $10,754
March 31, 2023 $15,301

I think your right,latest 10k show’s employee stock program approved,10.75M cash on hand,look at latest quarterly to see cash used to figure burn rate,they have no revenue yet unfortunately, FINVIS might show a burn rate(lots of great info,I use it often,scanner is best I have ever used,lots of factors)

Might be the employees purchasing stock or the company. Their employee stock program was just passed.

What I want to know is what their burn rate is in cash. Anyone know how to calculate that?

Buying volume up 55Xs ave today,10 day ave vol up 11Xs

Product is world changing,it will get found

Predictable Bullish chart,no news YET! Loaded and holding for it,under the radar with all the big runners today getting chased

ONVO under $2

Updated Investor Presentation.

https://ir.organovo.com/static-files/3e5d2de6-6ca0-4404-a527-dbdc4461e0f0

Anyone know how much cash they have and what their burn rate is?

ONVO under $2

HC Wainwright Presentation up. ONVO management is now moving.

https://ir.organovo.com/investor-presentations

Almost back down below a buck..

First presentation update in 2 years.

https://ir.organovo.com/investor-presentations

They have drastically changed their business model in the last 5 years. They are a full on drug company now.

ONVO...........................https://stockcharts.com/h-sc/ui?s=ONVO&p=W&b=5&g=0&id=p86431144783

this needs to get pumped by Redditors

When it reaches 72$/share, I'll have fun lol

I’m having fun… anyone else?

Buyers are back

Or turn the lights off lol

Back over 2.65 heats up

Took some $1.90s and $2.10s premarket yesterday here but still holding premarket today. On watch another low floater

Everyone got out of this already? ONVO had a good day today!

It is showing some life here today. 10Q is out. I believe that is the reason.

-10/5/22 they held 1.416M shares at around $9 per share.

-They start unload since 1/6/21-3/30/21 for 929,307 shares.

-during that time it hit as high as $23 per share.

-after that, they are keeping unloading a little by little.

-as of 9/30/22, they still hold 271,860 shares.

-I wish I could send picture of what they did.

*IMO, they will keep unloading slowly and most likely, they will sell everything. ONVO was high risk, high return. Now IT IS “HIGHER RISK, HIGHER RETURN.” My wife needs liver transplant, I am hoping this company to do well, so whether risky or not, I bought some and holding. I am praying.

This one still held by Cathie Wood?

and down it goes


should have never seen 5's on todays news

+19% from +120%

thats just crazy

wonder what this does at the open and rest of the day

thats the dirty mm's and whoever else hyper extends these pops


+120% on todays news is just a joke

just goes to show how easily stocks are manipulated

especially low floaters

https://finviz.com/quote.ashx?t=ONVO&ty=c&ta=1&p=d

Pre-Market High $5.02 (04:11:14 AM) = +120%

volume already more than 1 million.

ONVO Chart

Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk
BY GlobeNewswire
— 12:00 PM ET 01/10/2022
SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (ONVO) , today released its first detailed response to the lawsuit Cellink filed against it in Delaware court in 2021. At issue in this lawsuit is whether Cellink is infringing Organovo (ONVO) patents. Organovo (ONVO), as one of the earliest and most prominent 3D bioprinting companies, has built a strong and foundational patent portfolio in the space. Organovo (ONVO) believes that Cellink, as a newer company with limited patent filings, has moved forward without regard to its patents and now is at risk of owing significant license fees and royalties to Organovo (ONVO).

Organovo (ONVO) is accusing Cellink of infringing several of Organovo’s patents, and thus Organovo (ONVO) filed counterclaims to the Delaware suit on Friday, January 7, 2022, and asserted an additional patent against Cellink. With trial set for April 2023, Organovo (ONVO) looks forward to a speedy outcome to the case, with the possibility to gain a damages award that might be tripled if Cellink is determined to have willfully infringed Organovo’s patents.

Organovo (ONVO) Executive Chairman Keith Murphy commented on the legal proceedings, “Organovo has a powerful foundational patent portfolio in the 3D bioprinting space. Cellink launched itself and grew to $1.5B market capitalization on the basis of bioprinting revenue streams Organovo (ONVO) now contends were achieved through unauthorized use of Organovo’s intellectual property. We look forward to the legal process to award Organovo (ONVO) its due share of the revenue that Cellink has only achieved due to such patent infringement. We believe that this revenue, and IP licensing revenue more broadly in the bioprinting space, will properly reward our investors for the early investment in intellectual property.”

Third parties recognized Organovo’s bioprinting IP as foundational and innovative as far back as 2015, before Cellink announced its first printer. Organovo (ONVO) welcomes the opportunity to hold Cellink accountable for the damages Organovo (ONVO) has incurred due to Cellink’s unauthorized use of Organovo’s IP.